AU6141798A - Drugs for memory enhancement - Google Patents

Drugs for memory enhancement

Info

Publication number
AU6141798A
AU6141798A AU61417/98A AU6141798A AU6141798A AU 6141798 A AU6141798 A AU 6141798A AU 61417/98 A AU61417/98 A AU 61417/98A AU 6141798 A AU6141798 A AU 6141798A AU 6141798 A AU6141798 A AU 6141798A
Authority
AU
Australia
Prior art keywords
drugs
memory enhancement
enhancement
memory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61417/98A
Inventor
Richard L Gabriel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson Matthey Pharmaceutical Materials Inc
Original Assignee
Pharm Eco Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharm Eco Laboratories Inc filed Critical Pharm Eco Laboratories Inc
Publication of AU6141798A publication Critical patent/AU6141798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU61417/98A 1997-02-05 1998-02-04 Drugs for memory enhancement Abandoned AU6141798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3688997P 1997-02-05 1997-02-05
US60036889 1997-02-05
PCT/US1998/002009 WO1998033498A1 (en) 1997-02-05 1998-02-04 Drugs for memory enhancement

Publications (1)

Publication Number Publication Date
AU6141798A true AU6141798A (en) 1998-08-25

Family

ID=21891226

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61417/98A Abandoned AU6141798A (en) 1997-02-05 1998-02-04 Drugs for memory enhancement

Country Status (6)

Country Link
EP (1) EP0969830A1 (en)
JP (1) JP2001512422A (en)
AU (1) AU6141798A (en)
BR (1) BR9807980A (en)
CA (1) CA2279947A1 (en)
WO (1) WO1998033498A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60229411D1 (en) * 2001-08-31 2008-11-27 Corcept Therapeutics Inc PROCESS FOR INHIBITING THE DESTRUCTION OF COGNITIVE PERFORMANCE IN ADULTS WITH DOWN SYNDROME
US20110237670A1 (en) 2008-12-12 2011-09-29 Daniel Klamer Improvement of normal cognitive function
CN112851622B (en) * 2019-11-28 2023-01-10 中国海洋大学 Macrolide brefeldin A ester derivative and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
US5696154A (en) * 1994-06-29 1997-12-09 The United States Of America As Represented By The Department Of Health And Human Services Brefeldin A derivatives and their utility in the treatment of cancer
WO1996009299A1 (en) * 1994-09-20 1996-03-28 The Regents Of The University Of California Drugs to improved synaptic transmission
US5618837A (en) * 1995-06-07 1997-04-08 Zymogenetics, Inc. PDGF antagonists III

Also Published As

Publication number Publication date
JP2001512422A (en) 2001-08-21
WO1998033498A1 (en) 1998-08-06
CA2279947A1 (en) 1998-08-06
BR9807980A (en) 2000-03-28
EP0969830A1 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
AU1151099A (en) Azaoxindole derivatives
AU1709299A (en) Mixer-injectors
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU1825899A (en) Dota-biotin derivatives
AU7012298A (en) Single-electron memory component
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU5387898A (en) Pharmaceutical agents
AU1027499A (en) 32P-polyphosphazene
AU7251798A (en) Memory integrated circuitry
AU1409100A (en) Drugs
AU8591898A (en) Pharmaceutical compounds
AU5272198A (en) EMP-charge-eliminator
AU7813598A (en) Betulinol derivatives
AU4117497A (en) Micropolarimeter
AU4001297A (en) Capsule
AU7038198A (en) Computer memory organization
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AU6185898A (en) Clavaspirins
AU7712796A (en) Memory aid
AU6115798A (en) Saponarin derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU6141798A (en) Drugs for memory enhancement
AU5386498A (en) Enhancement phalloplasty